Technology Archives - Page 7 of 9

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

November 12, 2025

THIS WEEK'S STORIES

ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues

November 11, 2025

Tandem Diabetes Care Appoints Sandra Beaver to Board of Directors

November 12, 2025

Niagen Bioscience Reports Results from First Randomized Controlled Trial of Niagen Supplementation in Individuals with Long COVID

November 13, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Technology

Salt AI Adds Biotech and AI Industry Leaders to Support Life Sciences Growth After $10 Million Funding Round

WVU Rockefeller Neuroscience Institute and Cognito Therapeutics Launch Brain Health Collaboratory to Accelerate AI-Driven Neurotherapy Innovation

AI for Every Practice: eClinicalWorks Survey Reveals Expanding Role of Artificial Intelligence in Healthcare

InterSystems Introduces HealthShare AI Assistant to Enhance Clinical Data Access and Decision-Making

MadeAi Expands AI-Driven Platform with New Tools for GVD and JCA Reporting

Most Read

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Cognision Partners with Kynexis to Use COGNISION System in Phase 2 Trial of KYN-5356 for Schizophrenia

Sensus Healthcare Expands Role of President Michael Sardano to Chief Commercial Officer

Dexcom Reveals Global Diabetes Advocates for World Diabetes Day

EDITOR PICKS

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

Parabilis Medicines Earns FDA Fast Track Designation for FOG-001 to Treat Desmoid Tumors

THIS WEEK'S STORIES

ByHeart Expands Voluntary Nationwide Recall of Infant Formula as Investigation Continues

Tandem Diabetes Care Appoints Sandra Beaver to Board of Directors

Niagen Bioscience Reports Results from First Randomized Controlled Trial of Niagen Supplementation in Individuals with Long COVID

POPULAR CATEGORY

ABOUT US

FOLLOW US